Clinical Trials Browser

Interventional × Breast Neoplasms × Silymarin × Clear all

NCT05595109 2022-10-26

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Phase 2/3 Unknown

Breast Neoplasms, Peripheral Nervous System Diseases, Cognitive Dysfunction, Cardiotoxicity

NCT04434404 2020-06-16

Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy

Phase 4 Completed

Breast Neoplasms, Cardiotoxicity